Resonance Health Ltd (AU:RHT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resonance Health Ltd, an Australian healthcare technology firm, is initiating a non-deal investor roadshow to showcase its innovative medical imaging software products, which leverage AI for non-invasive diagnostics. The company’s offerings, like FerriScan® and HepaFat-AI®, are globally recognized and used in clinical trials for their precision in diagnosing and managing diseases. With regulatory clearances in the USA, Europe, and Australia, Resonance Health continues to expand its footprint in the medical device industry.
For further insights into AU:RHT stock, check out TipRanks’ Stock Analysis page.